Verizon Communications Inc officer Kyle Malady filed a Form 144 notice of proposed sale of 1,100 shares of common stock on NYSE, with an approximate sale date of November 3, 2026, through Fidelity Brokerage Services LLC.

Key Highlights

  • Proposed sale: Kyle Malady, listed as an officer of Verizon Communications Inc, proposes to sell 1,100 shares of common stock with an aggregate market value of $49,269.00.
  • Source of shares: The 1,100 shares were acquired on March 1, 2026, via restricted stock vesting from the issuer, with compensation listed as the nature of payment.
  • Trading plan: The filing indicates reliance on a Rule 10b5-1 plan adopted on May 18, 2026.
  • Prior sales: Malady sold 1,100 shares on each of 11 separate dates between August 18, 2026, and October 27, 2026, with gross proceeds ranging from $47,223.00 to $56,309.00 per transaction.
  • Shares outstanding: According to the filing, 4,144,598,336 shares of Verizon common stock were outstanding at the time of the notice.
  • Broker: Sales are to be executed through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.

Malady's Proposed November 2026 Share Sale Under Rule 144

Verizon Communications Inc (NYSE:VZ), headquartered at 1095 Avenue of the Americas, New York, NY 10036, is the named issuer in a Form 144 notice filed on November 3, 2026. The filing identifies Kyle Malady, in the capacity of officer, as the person for whose account the securities are to be sold. The proposed sale covers 1,100 shares of Verizon common stock at an aggregate market value of $49,269.00, with the approximate date of sale listed as November 3, 2026.

According to the filing, the 1,100 shares subject to the proposed sale were acquired on March 1, 2026, through restricted stock vesting from the issuer, with compensation cited as the nature of payment. The notice also discloses that the sale is being made pursuant to a written trading plan adopted on May 18, 2026, indicating reliance on Rule 10b5-1 under the Exchange Act. The filing was signed by Corey Walter as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Kyle Malady.

The filing's required disclosure of securities sold during the prior three months shows that Malady sold 1,100 shares on each of 11 separate dates from August 18, 2026, through October 27, 2026. Gross proceeds per transaction ranged from $47,223.00 on October 13, 2026, to $56,309.00 on September 15, 2026. The filing lists total shares of Verizon common stock outstanding as 4,144,598,336.

What Was Disclosed

A Form 144 notice was filed on November 3, 2026, on behalf of Verizon officer Kyle Malady, covering a proposed sale of 1,100 shares of Verizon common stock acquired through restricted stock vesting, with sales to be conducted through Fidelity Brokerage Services LLC under a Rule 10b5-1 plan adopted May 18, 2026.